Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-06 Option Award | 2024-03-19 11:18 am | 2025-03-06 2034-03-06 | RENOVARO INC. | RENB | SAPIRSTEIN JAMES Director | 28,196 | $0 | 28,196 (Direct) | View |
| 2024-03-11 Option Award | 2024-03-13 3:50 pm | N/A 2034-03-11 | RENOVARO INC. | RENB | Tarsh Simon Interim CFO | 10,000 | $0 | 10,000 (Direct) | View |
| 2023-12-27 Option Award | 2024-02-28 3:20 pm | 2024-12-27 2033-12-27 | RENOVARO INC. | RENB | Brosgart Carol L Director | 23,810 | $0 | 23,810 (Direct) | View |
Ownership | 2024-02-23 5:01 pm | N/A N/A | RENOVARO INC. | RENB | Brink Karen Director 10% Owner | 0 | $0 | 27,226,486 (Indirect) | View |
| 2024-02-20 Exercise | 2024-02-22 4:35 pm | 2023-06-26 2028-06-26 | RENOVARO INC. | RENB | Sindlev Rene Director 10% Owner | 471,699 | $0 | 14,076,995 (Indirect) | View |
| 2024-02-20 Exercise | 2024-02-22 4:35 pm | N/A N/A | RENOVARO INC. | RENB | Sindlev Rene Director 10% Owner | 471,699 | $0.53 | 14,076,995 (Indirect) | View |
| 2024-02-13 Conversion | 2024-02-20 4:20 pm | 2023-08-01 N/A | RENOVARO INC. | RENB | Abildgaard Ole 10% Owner | 3,779,809 | $0 | 6,898,482 (Indirect) | View |
| 2023-10-03 Option Award | 2024-02-20 4:20 pm | N/A N/A | RENOVARO INC. | RENB | Abildgaard Ole 10% Owner | 1,000,000 | $0 | 6,898,482 (Indirect) | View |
| 2024-02-13 Option Award | 2024-02-16 09:44 am | 2024-02-13 2032-07-22 | RENOVARO INC. | RENB | Binette Francois COO and Executive VP for R&D | 170,000 | $0 | 170,000 (Direct) | View |
| 2024-02-13 Disposition | 2024-02-16 09:44 am | N/A 2032-07-22 | RENOVARO INC. | RENB | Binette Francois COO and Executive VP for R&D | 170,000 | $0 | 170,000 (Direct) | View |
Ownership(A) | 2024-02-16 09:38 am | 2023-04-18 2032-02-22 | RENOVARO INC. | RENB | Binette Francois COO and Executive VP for R&D | 0 | $0 | 65,000 (Direct) | View |
| 2024-02-13 Option Award | 2024-02-16 09:13 am | 2024-02-13 2029-06-06 | RENOVARO INC. | RENB | Puche Luisa Chief Financial Officer | 275,000 | $0 | 275,000 (Direct) | View |
| 2024-02-13 Disposition | 2024-02-16 09:13 am | N/A 2029-06-06 | RENOVARO INC. | RENB | Puche Luisa Chief Financial Officer | 275,000 | $0 | 275,000 (Direct) | View |
| 2024-02-13 Option Award | 2024-02-16 09:06 am | 2024-02-13 2028-02-28 | RENOVARO INC. | RENB | Dybul Mark Chief Executive Officer | 3,112,789 | $0 | 3,112,789 (Direct) | View |
| 2024-02-13 Disposition | 2024-02-16 09:06 am | N/A 2028-02-28 | RENOVARO INC. | RENB | Dybul Mark Chief Executive Officer | 3,112,789 | $0 | 3,112,789 (Direct) | View |
| 2024-02-13 Conversion | 2024-02-15 6:38 pm | 2023-08-01 N/A | RENOVARO INC. | RENB | Sindlev Rene Director 10% Owner | 771,386 | $0 | 13,133,598 (Indirect) | View |
| 2023-12-27 Option Award | 2024-02-02 12:14 pm | 2024-12-27 2033-12-27 | RENOVARO BIOSCIENCES INC. | RENB | Alton Gregg H Director | 23,810 | $0 | 23,810 (Direct) | View |
| 2023-10-23 Option Award | 2023-11-14 09:56 am | 2024-10-11 2033-10-11 | RENOVARO BIOSCIENCES INC. | RENB | Miller Avram Director | 1,027,147 | $0 | 1,027,147 (Direct) | View |
| 2023-10-04 Option Award | 2023-10-27 10:53 am | 2024-10-04 2033-10-04 | RENOVARO BIOSCIENCES INC. | RENB | Hendriks Ruud Director | 16,129 | $0 | 16,129 (Direct) | View |
| 2023-10-04 Option Award | 2023-10-25 10:56 am | 2024-10-04 2033-10-04 | RENOVARO BIOSCIENCES INC. | RENB | Boeren Leni Director | 16,129 | $0 | 16,129 (Direct) | View |
| 2023-10-09 Option Award | 2023-10-19 1:09 pm | 2024-10-09 2033-10-09 | RENOVARO BIOSCIENCES INC. | RENB | Gronfeldt-Sorensen Henrik Director | 17,242 | $0 | 17,242 (Direct) | View |
Ownership | 2023-10-06 4:32 pm | N/A N/A | RENOVARO BIOSCIENCES INC. | RENB | Abildgaard Ole 10% Owner | 0 | $0 | 10,162,447 (Indirect) | View |
| 2023-08-01 Option Award | 2023-09-12 06:08 am | 2023-08-01 2028-08-01 | RENOVARO BIOSCIENCES INC. | RENB | Sindlev Rene Director 10% Owner | 350,630 | $0 | 420,756 (Indirect) | View |
| 2023-08-01 Option Award | 2023-09-12 06:08 am | 2023-08-01 N/A | RENOVARO BIOSCIENCES INC. | RENB | Sindlev Rene Director 10% Owner | 70,126 | $7.13 | 420,756 (Indirect) | View |
| 2023-07-30 Option Award | 2023-08-01 7:47 pm | 2024-07-30 2033-07-30 | Enochian Biosciences Inc | ENOB | Sindlev Rene Director 10% Owner | 131,579 | $0 | 131,579 (Direct) | View |
| 2023-06-26 Option Award | 2023-06-27 8:29 pm | 2023-06-26 2028-06-26 | Enochian Biosciences Inc | ENOB | Sindlev Rene Director 10% Owner | 943,397 | $0 | 13,375,735 (Indirect) | View |
| 2023-06-26 Option Award | 2023-06-27 8:29 pm | N/A N/A | Enochian Biosciences Inc | ENOB | Sindlev Rene Director 10% Owner | 1,886,794 | $0.53 | 13,375,735 (Indirect) | View |
| 2023-05-26 Option Award | 2023-06-14 9:26 pm | 2024-05-26 2033-05-26 | Enochian Biosciences Inc | ENOB | McNicol Jayne Director | 79,787 | $0 | 79,787 (Direct) | View |
| 2023-03-06 Option Award | 2023-04-04 4:07 pm | 2024-03-06 2033-03-06 | Enochian Biosciences Inc | ENOB | SAPIRSTEIN JAMES Director | 64,655 | $0 | 64,655 (Direct) | View |
| 2023-03-17 Option Award | 2023-03-21 9:39 pm | 2023-03-17 2028-03-17 | Enochian Biosciences Inc | ENOB | Sindlev Rene Director 10% Owner | 438,597 | $0 | 10,984,141 (Indirect) | View |
| 2023-03-17 Option Award | 2023-03-21 9:39 pm | N/A N/A | Enochian Biosciences Inc | ENOB | Sindlev Rene Director 10% Owner | 877,193 | $1.14 | 10,984,141 (Indirect) | View |
| 2022-10-13 Other | 2023-02-06 7:31 pm | N/A N/A | Enochian Biosciences Inc | ENOB | William Anderson Wittekind 10% Owner | 1,216,467 | $0 | 20,172,843 (Indirect) | View |
Ownership | 2023-02-06 7:30 pm | N/A N/A | Enochian Biosciences Inc | ENOB | William Anderson Wittekind 10% Owner | 0 | $0 | 20,363,393 (Direct) | View |
| 2021-10-20 Ownership | 2023-02-06 7:30 pm | N/A N/A | Enochian Biosciences Inc | ENOB | William Anderson Wittekind 10% Owner | 7,400 | $0 | 20,363,393 (Direct) | View |
| 2022-04-11 Other | 2023-02-06 7:29 pm | N/A N/A | Enochian Biosciences Inc | ENOB | William Anderson Wittekind 10% Owner | 97,032 | $0 | 18,830,154 (Indirect) | View |
Ownership | 2023-02-06 7:27 pm | N/A N/A | Enochian Biosciences Inc | ENOB | William Anderson Wittekind 10% Owner | 0 | $0 | 21,277,474 (Direct) | View |
| 2020-08-25 Ownership | 2023-02-06 7:27 pm | N/A N/A | Enochian Biosciences Inc | ENOB | William Anderson Wittekind 10% Owner | 1,097,517 | $0 | 21,277,474 (Direct) | View |
| 2022-12-27 Option Award | 2023-01-05 4:48 pm | 2023-12-27 2032-12-27 | Enochian Biosciences Inc | ENOB | Alton Gregg H Director | 57,252 | $0 | 57,252 (Direct) | View |
| 2022-12-27 Option Award | 2023-01-05 4:47 pm | 2023-12-27 2032-12-27 | Enochian Biosciences Inc | ENOB | Brosgart Carol L Director | 57,252 | $0 | 57,252 (Direct) | View |
| 2022-10-18 Option Award | 2022-10-27 4:54 pm | N/A 2032-10-18 | Enochian Biosciences Inc | ENOB | Binette Francois Executive VP for R&D | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-10-18 Option Award | 2022-10-27 4:51 pm | N/A 2032-10-18 | Enochian Biosciences Inc | ENOB | Puche Luisa Chief Financial Officer | 80,000 | $0 | 80,000 (Direct) | View |
| 2022-10-09 Option Award | 2022-10-26 4:19 pm | 2023-10-09 2032-10-09 | Enochian Biosciences Inc | ENOB | Gronfeldt-Sorensen Henrik Director | 45,455 | $0 | 45,455 (Direct) | View |
| 2022-07-30 Option Award | 2022-10-25 4:21 pm | 2023-07-30 2032-07-30 | Enochian Biosciences Inc | ENOB | Sindlev Rene Director 10% Owner | 32,609 | $0 | 32,609 (Direct) | View |
| 2022-08-25 Option Award | 2022-09-15 12:36 pm | N/A 2032-08-25 | Enochian Biosciences Inc | ENOB | Dybul Mark Chief Executive Officer | 350,000 | $0 | 350,000 (Direct) | View |
Ownership | 2022-08-18 12:41 pm | 2023-01-22 2032-07-22 | Enochian Biosciences Inc | ENOB | Binette Francois Executive Vice President | 0 | $0 | 65,000 (Direct) | View |